Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Accounts Payables (2016 - 2025)

CV Sciences' Accounts Payables history spans 15 years, with the latest figure at $1.0 million for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 45.77% to $1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 million, a 45.77% decrease, with the full-year FY2025 number at $1.0 million, down 45.77% from a year prior.
  • Accounts Payables hit $1.0 million in Q4 2025 for CV Sciences, down from $1.2 million in the prior quarter.
  • Over the last five years, Accounts Payables for CVSI hit a ceiling of $2.7 million in Q1 2022 and a floor of $646000.0 in Q2 2021.
  • Historically, Accounts Payables has averaged $1.9 million across 5 years, with a median of $2.2 million in 2022.
  • Biggest five-year swings in Accounts Payables: skyrocketed 282.82% in 2022 and later crashed 45.77% in 2025.
  • Tracing CVSI's Accounts Payables over 5 years: stood at $2.6 million in 2021, then fell by 12.96% to $2.3 million in 2022, then grew by 1.09% to $2.3 million in 2023, then decreased by 16.63% to $1.9 million in 2024, then crashed by 45.77% to $1.0 million in 2025.
  • Business Quant data shows Accounts Payables for CVSI at $1.0 million in Q4 2025, $1.2 million in Q3 2025, and $1.4 million in Q2 2025.